---
figid: PMC7272282__nihms-1584179-f0001
figtitle: PI3K pathway
organisms:
- NA
pmcid: PMC7272282
filename: nihms-1584179-f0001.jpg
figlink: /pmc/articles/PMC7272282/figure/F1/
number: F1
caption: 'Upon RTK activation induced by growth factors, PI3K phosphorylates PI(3,4)P2
  to generate PI(3,4,5)P3. PI(3,4,5)P3 then recruits PDK1 to activate AKT. Individal
  isoforms of PI3K or AKT are not shown here. mTOR is downstream of AKT. The mTOR
  complex consists of two components; mTORC1-Raptor and mTORC2-Rictor. AKT directly
  activates mTOR via phosphorylating mTORC1 or indirectly activates mTORC1 by inhibiting
  TSC 1/2. mTORC1 phosphorylates the 4E-BP1 and the S6K, which consequently enhances
  the translation of mRNA encoding proteins, responsible for cell survival (i.e.,
  survivin), proliferation (i.e., Forkhead box O family) and DNA damage response (i.e.,
  BRCA1). There are positive and negative feedback loops for active PI3K signaling.
  mTORC2 triggers positive feedback on PI3K pathway activation by phosphorylating
  AKT at Ser473. PTEN and INPP4B negatively regulate the PI3K pathway via converting
  PI(3,4,5)P3 back to inactive forms, thus impairing AKT activation. Abbreviations:
  4E-BP1 = eukaryotic initiation factor 4E binding protein 1; eIF4E = eukaryotic initiation
  factor 4E; GPCR = G-protein coupled receptor; INPP4B = inositol Polyphosphate 4-phosphatase
  type II; mTORC = mammalian target of rapamycin complex; PDK1 = phosphoinositide
  dependent kinases 1; PI3K = phosphatidylinositol 3-kinase; PI3P = phosphatidylinositol
  3-phosphate; PI(3,4)P2= phosphatidylinositol-3,4-bisphosphate; PI(4,5)P2 = phosphatidylinositol-4,5-bisphosphate;
  PI(3,4,5)P3 = phosphatidylinositol-3,4,5-trisphosphate; PTEN = tumor suppressor
  phosphatase and tensin homolog; RTK = receptor tyrosine kinase; S6 = ribosomal protein
  S6; S6K = ribosomal protein S6 kinase; SHP1/2 = SH-2 containing inositol 5'' polyphosphatase
  1/2; TSC1/2 = tuberous sclerosis complex 1 and 2'
papertitle: Targeting the PI3K pathway and DNA damage response as a therapeutic strategy
  in ovarian cancer.
reftext: Tzu-Ting Huang, et al. Cancer Treat Rev. ;86:102021-102021.
year: '2020'
doi: 10.1016/j.ctrv.2020.102021
journal_title: Cancer treatment reviews
journal_nlm_ta: Cancer Treat Rev
publisher_name: ''
keywords: PI3K/AKT/mTOR pathway | DNA damage response | cell cycle checkpoint | DNA
  repair | ovarian cancer
automl_pathway: 0.9381822
figid_alias: PMC7272282__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7272282__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7272282__nihms-1584179-f0001.html
  '@type': Dataset
  description: 'Upon RTK activation induced by growth factors, PI3K phosphorylates
    PI(3,4)P2 to generate PI(3,4,5)P3. PI(3,4,5)P3 then recruits PDK1 to activate
    AKT. Individal isoforms of PI3K or AKT are not shown here. mTOR is downstream
    of AKT. The mTOR complex consists of two components; mTORC1-Raptor and mTORC2-Rictor.
    AKT directly activates mTOR via phosphorylating mTORC1 or indirectly activates
    mTORC1 by inhibiting TSC 1/2. mTORC1 phosphorylates the 4E-BP1 and the S6K, which
    consequently enhances the translation of mRNA encoding proteins, responsible for
    cell survival (i.e., survivin), proliferation (i.e., Forkhead box O family) and
    DNA damage response (i.e., BRCA1). There are positive and negative feedback loops
    for active PI3K signaling. mTORC2 triggers positive feedback on PI3K pathway activation
    by phosphorylating AKT at Ser473. PTEN and INPP4B negatively regulate the PI3K
    pathway via converting PI(3,4,5)P3 back to inactive forms, thus impairing AKT
    activation. Abbreviations: 4E-BP1 = eukaryotic initiation factor 4E binding protein
    1; eIF4E = eukaryotic initiation factor 4E; GPCR = G-protein coupled receptor;
    INPP4B = inositol Polyphosphate 4-phosphatase type II; mTORC = mammalian target
    of rapamycin complex; PDK1 = phosphoinositide dependent kinases 1; PI3K = phosphatidylinositol
    3-kinase; PI3P = phosphatidylinositol 3-phosphate; PI(3,4)P2= phosphatidylinositol-3,4-bisphosphate;
    PI(4,5)P2 = phosphatidylinositol-4,5-bisphosphate; PI(3,4,5)P3 = phosphatidylinositol-3,4,5-trisphosphate;
    PTEN = tumor suppressor phosphatase and tensin homolog; RTK = receptor tyrosine
    kinase; S6 = ribosomal protein S6; S6K = ribosomal protein S6 kinase; SHP1/2 =
    SH-2 containing inositol 5'' polyphosphatase 1/2; TSC1/2 = tuberous sclerosis
    complex 1 and 2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PDK1
  - PDPK1
  - SERPINA4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TSC2
  - TSC1
  - CCL26
  - MTOR
  - RPTOR
  - COL4A1
  - AKT1
  - AKT2
  - AKT3
  - RPS6KB1
  - EIF4EBP1
  - PTEN
  - EIF4E
  - EIF4E2
  - EIF4E3
  - INPPL1
  - INPP5D
  - MAPKAP1
  - RICTOR
  - MLST8
  - PI3
  - INPP4B
---
